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Impact of pre-hospital antibiotic use on community-acquired pneumonia
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Abstract
Information on the inﬂuence of pre-hospital antibiotic treatment on the causative organisms, clinical features and outcomes of patients with
community-acquired pneumonia (CAP) remains scarce. We performed an observational study of a prospective cohort of non-immuno-
suppressed adults hospitalized with CAP between 2003 and 2012. Patients were divided into two groups: those who had received
pre-hospital antibiotic treatment for the same episode of CAP and those who had not. A propensity score was used to match patients. Of
2179 consecutive episodes of CAP, 376 (17.3%) occurred in patients who had received pre-hospital antibiotic treatment. After propensity
score matching, Legionella pneumophila was more frequently identiﬁed in patients with pre-hospital antibiotic treatment, while Streptococcus
pneumoniae was less common (p <0.001 and p <0.001, respectively). Bacteraemia was less frequent in pre-treated patients (p 0.01). The
frequency of positive sputum culture and the sensitivity and speciﬁcity of the pneumococcal urinary antigen test for diagnosing
pneumococcal pneumonia were similar in the two groups. Patients with pre-hospital antibiotic treatment were less likely to present fever
(p 0.02) or leucocytosis (p 0.001). Conversely, chest X-ray cavitation was more frequent in these patients (p 0.04). No signiﬁcant
differences were found in the frequency of patients classiﬁed into high-risk Pneumonia Severity Index classes, in intensive care unit
admission, or in 30-day mortality between the groups. In conclusion, L. pneumophila occurrence was nearly three times higher in patients
who received pre-hospital antibiotics. After a propensity-adjusted analysis, no signiﬁcant differences were found in prognosis between study
groups. Pre-hospital antibiotic use should be considered when choosing aetiological diagnostic tests and empirical antibiotic therapy in
patients with CAP.
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